Coriat R - Search Results

1

Gougis P, Paci A, Coriat R, Urien S, Mir O. Gougis P, et al. Among authors: coriat r. Lancet Oncol. 2015 Jul;16(7):e311. doi: 10.1016/S1470-2045(15)00065-0. Lancet Oncol. 2015. PMID: 26149879 No abstract available.

2

Ambulatory administration of 5-day infusion ifosfamide+mesna: a pilot study in sarcoma patients.

Coriat R, Mir O, Camps S, Ropert S, Billemont B, Leconte M, Larousserie F, Anract P, Alexandre J, Goldwasser F. Coriat R, et al. Cancer Chemother Pharmacol. 2010 Feb;65(3):491-5. doi: 10.1007/s00280-009-1054-1. Epub 2009 Jul 9. Cancer Chemother Pharmacol. 2010. PMID: 19588140 Clinical Trial.

3

Avascular necrosis of the femoral head: a rare class-effect of anti-VEGF agents.

Mir O, Coriat R, Gregory T, Ropert S, Billemont B, Goldwasser F. Mir O, et al. Among authors: coriat r. Invest New Drugs. 2011 Aug;29(4):716-8. doi: 10.1007/s10637-010-9406-6. Epub 2010 Feb 24. Invest New Drugs. 2011. PMID: 20177735 No abstract available.

4

Pneumatosis intestinalis associated with treatment of cancer patients with the vascular growth factor receptor tyrosine kinase inhibitors sorafenib and sunitinib.

Coriat R, Ropert S, Mir O, Billemont B, Chaussade S, Massault PP, Blanchet B, Vignaux O, Goldwasser F. Coriat R, et al. Invest New Drugs. 2011 Oct;29(5):1090-3. doi: 10.1007/s10637-010-9458-7. Epub 2010 Jun 5. Invest New Drugs. 2011. PMID: 20524036

5

Reactivation of tuberculosis during temsirolimus therapy.

Coriat R, Mir O, Ropert S, Loulergue P, Billemont B, Goldwasser F. Coriat R, et al. Invest New Drugs. 2011 Dec;29(6):1494-6. doi: 10.1007/s10637-010-9487-2. Epub 2010 Jul 10. Invest New Drugs. 2011. PMID: 20623161

6

Pharmacokinetic interaction involving sorafenib and the calcium-channel blocker felodipine in a patient with hepatocellular carcinoma.

Gomo C, Coriat R, Faivre L, Mir O, Ropert S, Billemont B, Dauphin A, Tod M, Goldwasser F, Blanchet B. Gomo C, et al. Among authors: coriat r. Invest New Drugs. 2011 Dec;29(6):1511-4. doi: 10.1007/s10637-010-9514-3. Epub 2010 Aug 13. Invest New Drugs. 2011. PMID: 20706860

7

Feasibility of oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX-4) in cirrhotic or liver transplant patients: experience in a cohort of advanced hepatocellular carcinoma patients.

Coriat R, Mir O, Cessot A, Brezault C, Ropert S, Durand JP, Cacheux W, Chaussade S, Goldwasser F. Coriat R, et al. Invest New Drugs. 2012 Feb;30(1):376-81. doi: 10.1007/s10637-010-9525-0. Epub 2010 Aug 27. Invest New Drugs. 2012. PMID: 20798975

8

Treatment of bevacizumab-induced hypertension by amlodipine.

Mir O, Coriat R, Ropert S, Cabanes L, Blanchet B, Camps S, Billemont B, Knebelmann B, Goldwasser F. Mir O, et al. Among authors: coriat r. Invest New Drugs. 2012 Apr;30(2):702-7. doi: 10.1007/s10637-010-9549-5. Epub 2010 Sep 29. Invest New Drugs. 2012. PMID: 20878444

9

Safety of 10 min infusion of bevacizumab in combination with 5FU-based chemotherapy in non-selected metastatic colorectal cancer patients.

Coriat R, Mir O, Chaussade S, Goldwasser F. Coriat R, et al. Dig Liver Dis. 2011 Mar;43(3):248-9. doi: 10.1016/j.dld.2010.10.013. Epub 2010 Dec 9. Dig Liver Dis. 2011. PMID: 21145299 No abstract available.

10

Reversible decrease of portal venous flow in cirrhotic patients: a positive side effect of sorafenib.

Coriat R, Gouya H, Mir O, Ropert S, Vignaux O, Chaussade S, Sogni P, Pol S, Blanchet B, Legmann P, Goldwasser F. Coriat R, et al. PLoS One. 2011 Feb 14;6(2):e16978. doi: 10.1371/journal.pone.0016978. PLoS One. 2011. PMID: 21340026 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

351 results

Search Page